Evidence map›Paper›PMID 36615340›Full record

ArticleMolecules (Basel, Switzerland)2022

Global Analysis of

Rita Afriyie Boateng, James L Myers-Hansen, Nigel N O Dolling, Benedicta A Mensah, Elia Brodsky, Mohit Mazumder, Anita Ghansah

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Prevalence ofPathogens (Basel, Switzerland) · 2026
    Article
  2. Deciphering the Impact of Mutations onMolecules (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rita Afriyie BoatengNoguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Accra P.O. Box LG 581, Ghana.
James L Myers-HansenNoguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Accra P.O. Box LG 581, Ghana.
Nigel N O DollingNoguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Accra P.O. Box LG 581, Ghana.ORCID 0000-0001-5598-0753
Benedicta A MensahNoguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Accra P.O. Box LG 581, Ghana.
Elia BrodskyPine Biotech, Inc., 1441 Canal St., New Orleans, LA 70112, USA.ORCID 0000-0003-3068-416X
Mohit MazumderPine Biotech, Inc., 1441 Canal St., New Orleans, LA 70112, USA.ORCID 0000-0002-2593-725X
Anita GhansahNoguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Accra P.O. Box LG 581, Ghana.

Funding

DELTAS Africa Initiative under Wellcome Trust (DELGEME grant number 107740/Z/15/Z) 107740/Z/15/Z
6 · The paper itself

Abstract

The continual rise in sulfadoxine (SDX) resistance affects the therapeutic efficacy of sulfadoxine-pyrimethamine; therefore, careful monitoring will help guide its prolonged usage. Mutations in

Indexed as

AntimalarialsDihydropteroate SynthaseMalaria, FalciparumPlasmodium falciparumChildDrug CombinationsDrug ResistanceFemaleHumansMolecular Docking SimulationMutationPregnancySulfadoxineTetrahydrofolate DehydrogenaseAntimalarialsDihydropteroate SynthaseDrug CombinationsSulfadoxineTetrahydrofolate Dehydrogenasehaplotypemalariamolecular dockingmolecular dynamics simulationsmutationsPfdhpssulfadoxine resistance

Identifiers

PMID36615340
PMCPMC9822128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.